Completed NA INTERVENTIONAL 2-arm NCT04693104

Intra-articular PVA Hydrogel in Knee Osteoarthritis

Effects of PVA Hydrogel in Comparison With Synvisc-One®, in Patients With Knee Osteoarthritis

Sponsor: Rottapharm Biotech

Updated 3 times since 2021 Last updated: Dec 31, 2020 Started: Oct 1, 2019 Primary completion: May 20, 2020 Completion: May 20, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Knee Osteoarthritis and is currently completed. Rottapharm Biotech leads this study, which shows 3 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Feb 2021 — Jul 2024 [monthly]

Completed NA

First recorded

Oct 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rottapharm Biotech

Data source: Rottapharm Biotech

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Świdnik, Poland